A new trading day began on Tuesday, with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stock price up 3.03% from the previous day of trading, before settling in for the closing price of $100.34. JAZZ’s price has ranged from $95.49 to $148.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 13.88% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 11.40%. With a float of $57.97 million, this company’s outstanding shares have now reached $60.63 million.
In an organization with 2800 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 84.57%, operating margin of 17.86%, and the pretax margin is 11.56%.
Jazz Pharmaceuticals plc (JAZZ) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Jazz Pharmaceuticals plc is 4.54%, while institutional ownership is 97.78%. The most recent insider transaction that took place on Apr 01 ’25, was worth 185,625. In this transaction Chairman & CEO of this company sold 1,500 shares at a rate of $123.75, taking the stock ownership to the 440,307 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Officer proposed sale 2,000 for $125.31, making the entire transaction worth $250,625.
Jazz Pharmaceuticals plc (JAZZ) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.88% during the next five years compared to -1.00% drop over the previous five years of trading.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Trading Performance Indicators
Here are Jazz Pharmaceuticals plc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.54. Likewise, its price to free cash flow for the trailing twelve months is 4.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 8.70, a number that is poised to hit 4.73 in the next quarter and is forecasted to reach 22.67 in one year’s time.
Technical Analysis of Jazz Pharmaceuticals plc (JAZZ)
Let’s dig in a bit further. During the last 5-days, its volume was 0.94 million. That was inferior than the volume of 1.02 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 39.94%. Additionally, its Average True Range was 5.52.
During the past 100 days, Jazz Pharmaceuticals plc’s (JAZZ) raw stochastic average was set at 15.01%, which indicates a significant decrease from 24.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.50% in the past 14 days, which was higher than the 35.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $127.75, while its 200-day Moving Average is $118.43. However, in the short run, Jazz Pharmaceuticals plc’s stock first resistance to watch stands at $104.42. Second resistance stands at $105.46. The third major resistance level sits at $107.06. If the price goes on to break the first support level at $101.78, it is likely to go to the next support level at $100.18. Assuming the price breaks the second support level, the third support level stands at $99.14.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Key Stats
With a market capitalization of 6.28 billion, the company has a total of 60,732K Shares Outstanding. Currently, annual sales are 4,069 M while annual income is 560,120 K. The company’s previous quarter sales were 1,088 M while its latest quarter income was 191,120 K.
